Efficacy and safety of modified fluorouracil/leucovorin plus irinotecan and oxaliplatin (mFOLFIRINOX) compared with S‐1 as second‐line chemotherapy in metastatic pancreatic cancer

BACKGROUND AND AIM: The optimal standard second‐line chemotherapy for metastatic pancreatic cancer (MPC) remains unclear. Here, we evaluated the efficacy and safety of modified fluorouracil/leucovorin plus irinotecan and oxaliplatin (mFOLFIRINOX) compared with oral fluoropyrimidine S‐1 as a second‐l...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikezawa, Kenji, Kiyota, Ryosuke, Takada, Ryoji, Daiku, Kazuma, Maeda, Shingo, Imai, Toshihiro, Abe, Yutaro, Kai, Yugo, Yamai, Takuo, Fukutake, Nobuyasu, Nakabori, Tasuku, Ashida, Reiko, Uehara, Hiroyuki, Tabuchi, Takahiro, Katayama, Kazuhiro, Ohkawa, Kazuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171163/
https://www.ncbi.nlm.nih.gov/pubmed/34124386
http://dx.doi.org/10.1002/jgh3.12555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171163/
https://www.ncbi.nlm.nih.gov/pubmed/34124386
http://dx.doi.org/10.1002/jgh3.12555

Ejemplares similares